These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14463327)

  • 1. [Survey of lipid metabolism in 100 patients suspected of atherosclerosis. Therapeutic trial of a new synthetic heparinoid: CB 8061. (Apropos of 30 cases)].
    LEBLOIS J; LESAGE R; RIVET E
    Lille Med; 1962 Mar; 7():256-63. PubMed ID: 14463327
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects of the hypocholesterolemic and clearing action of a heparinoid and its relation to atherosclerosis].
    ALMAFARA ML; ORLANDO MM
    Sem Med; 1962 Mar; 120():433-6. PubMed ID: 13860649
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE SIGNIFICANCE OF INSUFFICIENT CLEARANCE IN ATHEROGENESIS].
    SCHOEN H
    Munch Med Wochenschr; 1963 Dec; 105():2473-8. PubMed ID: 14133657
    [No Abstract]   [Full Text] [Related]  

  • 4. HEPARIN-LIKE SUBSTANCES AND ATHEROSCLEROSIS; A CLINICAL SURVEY AFTER FOUR YEARS OF THERAPEUTIC USE OF A DUODENAL HEPARINOID.
    COSTA U; AZZENA D; ASTENGO F; GHIGLIOTTI G
    G Gerontol; 1964 Feb; 12():201-2. PubMed ID: 14163031
    [No Abstract]   [Full Text] [Related]  

  • 5. [ACTION OF A SYNTHETIC HEPARINOID ON THE HUMORAL SYNDROME OF ATHEROSCLEROSIS].
    RAYNAUD R; BROCHIER ; TADEI
    Rev Atheroscler; 1963; 5():23-31. PubMed ID: 14121729
    [No Abstract]   [Full Text] [Related]  

  • 6. [USE OF A SYNTHETIC HEPARINOID: CB 8061. CONSIDERATIONS ON 50 CASES AFTER 10 MONTHS OF CLINICAL AND BIOLOGICAL TRIALS].
    MANS J; GENES M
    J Med Bord; 1963 Dec; 140():1886-93. PubMed ID: 14099058
    [No Abstract]   [Full Text] [Related]  

  • 7. [THERAPEUTIC TRIAL OF A SYNTHETIC HEPARINOID IN ARTERIAL DISEASES OF THE EXTREMITIES (CAUSED BY ATHEROSCLEROSIS)].
    PIERRON J
    Mars Med; 1963; 100():1267-74. PubMed ID: 14103616
    [No Abstract]   [Full Text] [Related]  

  • 8. THE EFFECT OF TRIPARANOL AND OF HEPARINOID ON SPONTANEOUS ATHEROSCLEROSIS OF HENS.
    MALINOW MR; MARINI MA; LEMA B; NEBBIA M; BERARDI JA
    Acta Physiol Lat Am; 1964; 14():71-6. PubMed ID: 14175168
    [No Abstract]   [Full Text] [Related]  

  • 9. [ACTION OF ORAL HEPARINOIDS ON METABOLISM OF LIPIDS].
    BOSTANCI N; BASAR M
    Turk Tip Cemiy Mecm; 1964 Sep; 30():564-70. PubMed ID: 14224677
    [No Abstract]   [Full Text] [Related]  

  • 10. [CLINICAL TRIALS OF A NEW SYNTHETIC HEPARINOID: CB-8,061].
    CHASSAGNON C; PERRIN A; MEY JP
    Lyon Med; 1963 Dec; 210():1125-41. PubMed ID: 14100236
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolism of lipids and atherosclerosis].
    VALDIGUIE P
    Lille Med; 1961 Nov; 6():853-67. PubMed ID: 13924304
    [No Abstract]   [Full Text] [Related]  

  • 12. FIRST RESULTS ON THE TREATMENT OF DISLIPEMIAS OBTAINED WITH THE USE OF A PANCREATIC HEPARIN-LIKE SUBSTANCE.
    AZZENA D; GHIGLIOTTI G; ASTENGO F; MOLINELLI G
    G Gerontol; 1964 Feb; 12():169-70. PubMed ID: 14163027
    [No Abstract]   [Full Text] [Related]  

  • 13. [CLEARING ACTION OF HEPARIN AND HEPARINOID SUBSTANCES IN THERAPY OF ARTERIOSCLEROSIS].
    MEONI G
    Clin Ter; 1965 Mar; 32():445-60. PubMed ID: 14333171
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical studies in blood lipid metabolism. IV. Abnormal lipid metabolism and atherosclerosis; preliminary report.
    GOLDBLOOM AA; POMERANZE J
    Am J Dig Dis; 1952 Sep; 19(9):281-3. PubMed ID: 12976373
    [No Abstract]   [Full Text] [Related]  

  • 15. On the effect of alimentary lipemia and a natural heparinoid on the fibrinolytic system of man.
    KONTTINEN Y
    Scand J Clin Lab Invest; 1962; 14():87-99. PubMed ID: 14458289
    [No Abstract]   [Full Text] [Related]  

  • 16. [USE OF A SYNTHETIC HEPARINOID IN LIPID METABOLISM DISORDERS. PRELIMINARY STUDY].
    RABY C; SAINT-BLANCARD J; PAGE G; BIED B; VIGNE J; OUGIER J
    Sem Ther; 1963 Dec; 39():658-64. PubMed ID: 14116089
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological efficacy of a treatment by a semisynthetic heparinoid. Apropos of approximately 100 cases].
    Thiercelin PC; Saint-Blancard J; Raby C
    Ann Biol Clin (Paris); 1965; 23(7):883-94. PubMed ID: 4158605
    [No Abstract]   [Full Text] [Related]  

  • 18. [On oral treatment with heparin and heparinoids].
    HEYMANN W
    Bibl Haematol; 1963; 15():132-9. PubMed ID: 13954327
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of lipid accumulation in atherogenesis.
    COURTICE FC
    Am Heart J; 1960 Oct; 60():664-5. PubMed ID: 13695989
    [No Abstract]   [Full Text] [Related]  

  • 20. [The blood, hepatic and aortic lipids in chronic experimental carbon disulfide poisoning in rabbits. Action of duodenal heparinoid extract].
    NICROSINI F; PASOTTI C; DEL FAVERO A; RICOTTI V; MARCHESI E
    Arch Sci Med (Torino); 1963 Feb; 115():109-28. PubMed ID: 13938462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.